Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
Sponsor: Memorial Sloan Kettering Cancer Center
Listed as NCT02106611, this observational or N/A phase trial focuses on Hodgkin Lymphoma Survivor and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 17 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
17 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 12 earlier versions
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Jan 2023 — Jan 2024 [monthly]
Active Not Recruiting
-
Jun 2022 — Jan 2023 [monthly]
Active Not Recruiting
-
Jun 2021 — Jun 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2017 — Jan 2018 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .